Johnson & Johnson 2017 Actelion Acquisition Value Proposition

Johnson & Johnson presents the value proposition for its acquisition of Actelion Ltd., featuring leadership speakers including CEO Alex Gorsky and Chief Scientific Officer Paul Stoffels. The presentation outlines expected benefits and strategic rationale for the transaction, subject to regulatory approvals and closing conditions.